A Liquid Pharmaceutical Formulation Comprising Nicotine For The Administration To The Oral Cavity

Patent No. EP2186507 (titled "A Liquid Pharmaceutical Formulation Comprising Nicotine For The Administration To The Oral Cavity") was filed by Mcneil on Dec 18, 2002. The application was issued on Apr 1, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALIUD PHARMAMar 17, 2021HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
FERTIN PHARMAJan 4, 2016HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2186507

MCNEIL
Application Number
EP09002569A
Filing Date
Dec 18, 2002
Status
Revoked
May 4, 2024
Publication Date
Apr 1, 2015